Biofrontera Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	3.82	1.34	17.21	24.55	8.08	7.3
Short-Term Investments	0.02	0.08	10.55	0	0	0
Cash & Cash Equivalents	3.84	1.42	27.76	24.55	8.08	7.3
Cash Growth	-81.80%	-94.88%	13.08%	203.77%	10.65%	-
Receivables	3.69	5.16	7.41	12.43	3.29	4.79
Inventory	6.91	10.91	7.17	4.46	7.09	10.48
Other Current Assets	5.72	5.58	0.81	4.99	1.12	0.9
Total Current Assets	20.16	23.08	43.14	46.42	19.58	23.47
Property, Plant & Equipment	1.54	1.75	1.58	0.27	0.37	0.5
Goodwill and Intangibles	2.56	2.63	3.03	3.45	3.87	4.29
Other Long-Term Assets	0.33	0.48	3.13	3.08	0.32	0.49
Total Long-Term Assets	4.42	4.86	7.74	6.8	4.56	5.28
Total Assets	24.58	27.93	50.88	53.22	24.14	28.75
Accounts Payable	6.76	9.01	2.59	1.6	1.71	7.81
Current Debt	3.05	4.6	0.5	0	0	0
Other Current Liabilities	4.23	4.49	17.81	12.24	2.71	3.93
Total Current Liabilities	14.04	18.09	20.89	13.84	4.42	11.74
Long-Term Debt	0.62	0.8	0.85	0	0	38.2
Other Long-Term Liabilities	11.76	4.25	5.26	28.05	13.89	8.99
Total Long-Term Liabilities	12.39	5.05	6.11	28.05	13.89	47.19
Total Liabilities	26.42	23.14	27.01	41.88	18.31	58.93
Total Debt	3.67	5.4	1.35	0	0	38.2
Debt Growth	203.23%	301.11%	-	-	-	-
Retained Earnings	-110.09	-99.65	-79.52	-78.88	-41.17	-30.18
Shareholders' Equity	-5.42	4.79	23.88	11.34	5.83	-30.18
Net Cash / Debt	0.17	-3.98	26.41	24.55	8.08	-30.9
Net Cash / Debt Growth	-99.13%	-	7.60%	203.77%	-	-
Net Cash Per Share	0.05	-2.57	24.99	55.73	7050.61	-617960.00
Working Capital	6.12	4.99	22.25	32.59	15.16	11.73
Book Value Per Share	-1.50	3.10	22.59	25.74	5086.62	-603580.00

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).